RetractedArticleOpen biology2019

HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.

Yafei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.